Log in to save to my catalogue

Halogenated Boroxine K 2 [B 3 O 3 F 4 OH] Modulates Metabolic Phenotype and Autophagy in Human Bladd...

Halogenated Boroxine K 2 [B 3 O 3 F 4 OH] Modulates Metabolic Phenotype and Autophagy in Human Bladd...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmed_primary_38930984

Halogenated Boroxine K 2 [B 3 O 3 F 4 OH] Modulates Metabolic Phenotype and Autophagy in Human Bladder Carcinoma 5637 Cell Line

About this item

Full title

Halogenated Boroxine K 2 [B 3 O 3 F 4 OH] Modulates Metabolic Phenotype and Autophagy in Human Bladder Carcinoma 5637 Cell Line

Publisher

Switzerland

Journal title

Molecules (Basel, Switzerland), 2024-06, Vol.29 (12)

Language

English

Formats

Publication information

Publisher

Switzerland

More information

Scope and Contents

Contents

Halogenated boroxine K
[B
O
F
OH] (HB), an inorganic derivative of cyclic anhydride of boronic acid, is patented as a boron-containing compound with potential for the treatment of both benign and malignant skin changes. HB has effectively inhibited the growth of several carcinoma cell lines. Because of the growing interest in autophagy...

Alternative Titles

Full title

Halogenated Boroxine K 2 [B 3 O 3 F 4 OH] Modulates Metabolic Phenotype and Autophagy in Human Bladder Carcinoma 5637 Cell Line

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmed_primary_38930984

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmed_primary_38930984

Other Identifiers

E-ISSN

1420-3049

DOI

10.3390/molecules29122919

How to access this item